U.S. Perficient, Target, Vertex Pharmaceuticals
May 7 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Perficient, Target and Vertex Pharmaceuticals, on Tuesday.
HIGHLIGHTS
* Cerence Inc CRNC.O: Needham cuts to hold from buy |
* Gap Inc GPS.N: Citigroup raises to buy from neutral |
* Perficient Inc PRFT.O: Alliance Global Partners cuts to neutral from buy |
* Target Corp TGT.N: Citigroup raises to buy from neutral |
* Vertex Pharmaceuticals Inc VRTX.O: Piper Sandler raises target price to $456 from $450 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Acadia Healthcare Company Inc ACHC.O: TD Cowen cuts target price to $91 from $101 |
* Adc Therapeutics SA ADCT.N: H.C. Wainwright cuts target price to $8 from $9 |
* Affiliated Managers Group Inc AMG.N: TD Cowen cuts target price to $198 from $218 |
* AG Mortgage Investment Trust Inc MITT.N: KBW raises target price to $7.50 from $7 |
* AIG AIG.N: BMO cuts target price to $88 from $91 |
* AIG AIG.N: Jefferies raises target price to $92 from $88 |
* Air Lease Corp AL.N: JP Morgan cuts target price to $54 from $55 |
* Air Lease Corp AL.N: TD Cowen cuts target price to $56 from $59 |
* Albemarle Corp ALB.N: Deutsche Bank raises target price to $140 from $125 |
* Alibaba Group BABA.N: Truist Securities cuts target price to $113 from $114 |
* Allegheny Technologies Inc ATI.N: JP Morgan raises target price to $65 from $53 |
* Allstate Corp ALL.N: BMO raises target price to $190 from $182 |
* Alnylam Pharmaceuticals Inc ALNY.O: H.C. Wainwright raises target to $400 from $395 |
* American Financial Group Inc AFG.N: BMO cuts target price to $133 from $136 |
* APA Corporation APA.O: Susquehanna raises target price to $57 from $54 |
* Archrock Inc AROC.N: RBC raises target price to $22 from $21 |
* Arcosa Inc ACA.N: Stephens raises target price to $96 from $89 |
* Ares Management Corp ARES.N: RBC raises target price to $150 from $145 |
* Ares Management Corp ARES.N: TD Cowen initiates coverage with buy rating; PT $154 |
* Arrow Electronics Inc ARW.N: Raymond James raises target price to $135 from $130 |
* Artivion Inc AORT.N: Needham raises target price to $30 from $25 |
* Artivion Inc AORT.N: Stifel raises target price to $25 from $22 |
* Ashland Inc ASH.N: BMO raises target price to $105 from $97 |
* Autozone Inc AZO.N: Citigroup cuts target price to $3420 from $3505 |
* Axon Enterprise Inc AXON.O: Craig-Hallum raises target price to $370 from $325 |
* Axon Enterprise Inc AXON.O: Raymond James raises target price to $400 from $330 |
* Axsome Therapeutics Inc AXSM.O: Citigroup cuts target price to $125 from $127 |
* Beacon Roofing Supply Inc BECN.O: Stephens raises target price to $107 from $95 |
* Best buy Co Inc BBY.N: Citigroup cuts target price to $67 from $76 |
* Biocryst Pharmaceuticals Inc BCRX.O: Piper Sandler raises target price to $20 from $19 |
* Bowlero Corp BOWL.N: Craig-Hallum raises target price to $18 from $17 |
* Bowlero Corp BOWL.N: Jefferies cuts target price to $29 from $30 |
* Bowlero Corp BOWL.N: Oppenheimer cuts target price to $15 from $18 |
* Bowlero Corp BOWL.N: Stifel cuts target price to $17 from $19 |
* BP BP.N: TD Cowen raises target price to $44 from $43 |
* Brightview Holdings Inc BV.N: JP Morgan raises target price to $11 from $8 |
* Builders Firstsource Inc BLDR.N: Wedbush cuts target price to $215 from $225 |
* BWX Technologies Inc BWXT.N: Deutsche Bank cuts target price to $110 from $111 |
* Cabot Corp CBT.N: Mizuho raises target price to $109 from $104 |
* Cabot Corp CBT.N: UBS raises target price to $103 from $100 |
* Cameco Corp CCJ.N: BofA Global Research adds stock to its US 1 list |
* Cardinal Health Inc CAH.N: Deutsche Bank cuts target price to $110 from $116 |
* Cardinal Health Inc CAH.N: Jefferies cuts target price to $105 from $110 |
* Cerence Inc CRNC.O: Needham cuts to hold from buy |
* Chewy Inc CHWY.N: Citigroup cuts target price to $16 from $18 |
* Children'S Place Inc PLCE.O: Telsey Advisory Group cuts target price to $9 from $13 |
* Cipher Mining Inc CIFR.O: H.C. Wainwright raises target price to $5.50 from $4.50 |
* City Holding Co CHCO.O: D.A. Davidson cuts target price by $1 to $107 |
* Civitas Resources Inc CIVI.N: Gerdes Energy Research raises target price by $2 to $115 |
* Cognex Corp CGNX.O: Truist Securities raises target price to $50 from $47 |
* Consolidated Edison Inc ED.N: Barclays raises target price to $97 from $89 |
* Constellation Energy Corp CEG.O: RBC raises target price to $211 from $119 |
* Corning Inc GLW.N: Mizuho initiates coverage with neutral rating; target price $36 |
* Corvus Pharmaceuticals CRVS.O: Oppenheimer raises target price to $8 from $7 |
* Coterra Energy Inc CTRA.N: Susquehanna raises target price to $33 from $32 |
* Coty Inc COTY.N: D.A. Davidson cuts target price to $16.50 from $17.50 |
* Crinetics Pharmaceuticals Inc CRNX.O: Piper Sandler raises PT to $97 from $56 |
* Crocs Inc CROX.O: Wedbush raises target price to $156 from $154 |
* Crown Castle Inc CCI.N: RBC cuts target price to $100 from $109 |
* CTO Realty Growth Inc CTO.N: Jonestrading cuts target price to $19 from $21 |
* CVS Health Corp CVS.N: TD Cowen cuts target price to $59 from $99 |
* CVS Health Corp CVS.N: TD Cowen cuts to hold from buy |
* Day One Biopharmaceuticals Inc DAWN.O: H.C. Wainwright cuts target to $40 from $50 |
* Design Therapeutics Inc DSGN.O: Piper Sandler raises target price to $12 from $6 |
* Design Therapeutics Inc DSGN.O: Piper Sandler raises to overweight from neutral |
* Dollar General Corp DG.N: BMO cuts target price to $150 from $160 |
* Dollar Tree Inc DLTR.O: BMO cuts target price to $150 from $160 |
* DR Horton Inc DHI.N: KBW raises target price to $178 from $172 |
* Driven Brands Holdings Inc. DRVN.O: Barclays cuts target price to $22 from $25 |
* eBay Inc EBAY.O: Deutsche Bank cuts target price to $56 from $58 |
* Edwards Lifesciences Corp EW.N: Barclays raises target price to $101 from $100 |
* Ehealth Inc EHTH.O: Craig-Hallum cuts target price to $6 from $7 |
* Eledon Pharmaceuticals Inc ELDN.O: H.C. Wainwright raises target price to $16 from $13 |
* Enact Holdings Inc ACT.O: BTIG raises target price to $33 from $30 |
* Enanta Pharmaceuticals Inc ENTA.O: H.C. Wainwright cuts target price to $27 from $28 |
* Enanta Pharmaceuticals Inc ENTA.O: Leerink Partners cuts target price to $12 from $13 |
* Enanta Pharmaceuticals Inc ENTA.O: Oppenheimer cuts target price to $16 from $17 |
* Equitable Holdings Inc EQH.N: KBW raises target price to $43 from $41 |
* Everquote Inc EVER.O: Craig-Hallum raises target price to $30 from $26 |
* Everquote Inc EVER.O: JP Morgan raises target price to $29 from $25 |
* Everquote Inc EVER.O: Needham raises target price to $30 from $25 |
* Exelon Corp EXC.O: RBC raises target price to $41 from $37 |
* Exxon Mobil Corp XOM.N: UBS raises target price to $152 from $150 |
* Eyepoint Pharmaceuticals Inc EYPT.O: Mizuho cuts target price to $30 from $39 |
* Fabrinet FN.N: Rosenblatt Securities raises target price to $260 from $230 |
* First Citizens Bancshares FCNCA.O: D.A. Davidson raises target price by $200 to $1,850 |
* FIS FIS.N: Evercore ISI raises target price to $80 from $75 |
* FIS FIS.N: Jefferies raises target price to $75 from $70 |
* FIS FIS.N: RBC raises target price to $82 from $75 |
* FMC Corp FMC.N: Mizuho raises target price to $57 from $55 |
* FMC Corp FMC.N: UBS raises target price to $86 from $84 |
* Freshpet Inc FRPT.O: D.A. Davidson raises target price to $153 from $138 |
* Freshpet Inc FRPT.O: Jefferies raises target price to $118 from $105 |
* Freshpet Inc FRPT.O: JP Morgan raises target price to $113 from $102 |
* Freshpet Inc FRPT.O: Oppenheimer raises target price to $135 from $120 |
* Freshpet Inc FRPT.O: Piper Sandler raises target price to $150 from $130 |
* Freshpet Inc FRPT.O: TD Cowen raises target price to $143 from $128 |
* Freshpet Inc FRPT.O: Wells Fargo raises target price to $140 from $124 |
* Frontier Communications Parent Inc FYBR.O: Citigroup raises target to $32 from $30 |
* Frontier Communications Parent Inc FYBR.O: Moffettnathanson raises PT to $30 from $28 |
* Fulton Financial Corp FULT.O: Stephens raises target price to $17.5 from $15.5 |
* Galiano Gold Inc GAU.N: H.C. Wainwright raises target price to $4.40 from $4.30 |
* Gap Inc GPS.N: Citigroup raises target price to $28 from $21 |
* Gap Inc GPS.N: Citigroup raises to buy from neutral |
* Gladstone Commercial Corp GOOD.O: Colliers Securities raises target price by $1 to $15 |
* Glycomimetics Inc GLYC.O: Jefferies cuts target price to $1 from $3 |
* Gossamer Bio Inc GOSS.O: Leerink Partners raises target price to $6 from $3 |
* Heidrick & Struggles International HSII.O: Truist Securities raises PT to $33 from $30 |
* Hims & Hers Health Inc HIMS.N: Deutsche Bank raises target price to $16 from $14 |
* Hims & Hers Health Inc HIMS.N: Guggenheim raises target price to $20 from $17 |
* Hims & Hers Health Inc HIMS.N: Leerink Partners cuts target price to $15 from $18 |
* Hims & Hers Health Inc HIMS.N: Piper Sandler raises target price to $13 from $11 |
* Home Depot Inc HD.N: Citigroup cuts target price to $395 from $415 |
* Homestreet Inc HMST.O: KBW cuts target price to $13.50 from $15.50 |
* Howmet Aerospace Inc HWM.N: JP Morgan raises target price to $83 from $60 |
* Huntsman Corp HUN.N: RBC raises target price to $26 from $24 |
* Ingersoll Rand Inc IR.N: Citigroup cuts target price to $110 from $112 |
* Ingersoll Rand Inc IR.N: Stifel cuts target price to $100 from $102 |
* Integra Lifesciences Holdings Corp IART.O: Jefferies cuts target price to $48 from $50 |
* Integra Lifesciences Holdings Corp IART.O: Morgan Stanley cuts target to $24 from $37 |
* Integra Lifesciences Holdings Corp IART.O: Oppenheimer cuts to perform from outperform |
* Integra Lifesciences Holdings Corp IART.O: Truist Securities cuts PT to $25 from $37 |
* International Flavors & Fragrances Inc IFF.N: Mizuho raises PT to $98 from $91 |
* International Flavors & Fragrances Inc IFF.N: Stifel raises PT to $95.00 from $87.00 |
* International Flavors & Fragrances Inc IFF.N: UBS raises target price to $95 from $90 |
* Intest Corp INTT.A: Northland Capital cuts target price to $15 from $17 |
* Kilroy Realty Corp KRC.N: Evercore ISI cuts target price to $39 from $40 |
* Lemonade Inc LMND.N: BMO raises target price to $11 from $10 |
* Lemonade Inc LMND.N: Jefferies raises target price to $16 from $14 |
* Liberty Latin America LILA.O: Barclays cuts target price to $8 from $9 |
* Lincoln Educational Services LINC.O: Barrington Research raises target to $14 from $13 |
* Lincoln Educational Services LINC.O: Rosenblatt Securities raises PT to $15 from $13.5 |
* Lowe's Companies Inc LOW.N: Citigroup cuts target price to $240 from $243 |
* Lumentum Holdings Inc LITE.O: Barclays cuts target price to $38 from $40 |
* Lumentum Holdings Inc LITE.O: Jefferies cuts target price to $53 from $57 |
* Lumentum Holdings Inc LITE.O: Raymond James cuts target price to $55 from $58 |
* Lumentum Holdings Inc LITE.O: UBS cuts target price to $51 from $52 |
* Lyra Therapeutics Inc LYRA.O: Jefferies cuts target price to $0.5 from $10 |
* Lyra Therapeutics Inc LYRA.O: Jefferies cuts to hold from buy |
* Marinus Pharmaceuticals Inc MRNS.O: H.C. Wainwright cuts target price to $11 |
* Marriott Vacations Worldwide Corp VAC.N: Stifel raises PT to $117.00 from $115.00 |
* Mastec Inc MTZ.N: D.A. Davidson raises target price to $120 from $100 |
* Mediaalpha Inc MAX.N: BMO raises target price to $31 from $28 |
* Metagenomi Inc MGX.O: H.C. Wainwright initiates coverage with buy rating |
* Metlife Inc MET.N: KBW cuts target price to $86 from $87 |
* Microchip Technology Inc MCHP.O: Citigroup raises target price to $104 from $100 |
* Microchip Technology Inc MCHP.O: Mizuho raises target price to $85 from $82 |
* Microchip Technology Inc MCHP.O: Needham raises target price to $100 from $90 |
* Microchip Technology Inc MCHP.O: Piper Sandler raises target price to $90 from $80 |
* Microchip Technology Inc MCHP.O: Raymond James raises target price to $105 from $100 |
* Microchip Technology Inc MCHP.O: Susquehanna raises target price to $105 from $100 |
* Microchip Technology Inc MCHP.O: TD Cowen raises target price to $90 from $80 |
* Microchip Technology Inc MCHP.O: Truist Securities raises target price to $96 from $93 |
* Microchip Technology Inc MCHP.O: UBS raises target price to $103 from $95 |
* Moderna Inc MRNA.O: UBS raises target price to $151 from $143 |
* Moneylion Inc ML.N: Craig-Hallum raises target price to $105 from $100 |
* Moody's Corp MCO.N: Stifel raises target price to $374 from $350 |
* MP Materials Corp MP.N: Deutsche Bank cuts target price to $14.5 from $15 |
* Napco Security Technologies Inc NSSC.O: D.A. Davidson raises target to $53 from $52 |
* Napco Security Technologies Inc NSSC.O: Needham raises target price to $52 from $46 |
* Nexpoint Real Estate Finance Inc NREF.N: KBW cuts target price to $13.50 from $14 |
* Nextera Energy Inc NEE.N: BMO raises target price to $78 from $72 |
* Nike Inc NKE.N: BofA Global Research adds stock to its US 1 list |
* Northwest Natural Holding Co NWN.N: Stifel raises target price to $40 from $39 |
* Nvidia Corp NVDA.O: Goldman Sachs raises target price to $1100 from $1000 |
* Offerpad Solutions Inc OPAD.N: JP Morgan cuts target price to $8 from $9 |
* Omnicom Group Inc OMC.N: Barclays raises target price to $110 from $100 |
* Omnicom Group Inc OMC.N: Barclays raises to overweight from equal-weight |
* Oric Pharmaceuticals Inc ORIC.O: Citigroup cuts target price to $14 from $15 |
* Orthopediatrics Corp KIDS.O: Needham raises target price to $42 from $37 |
* Ovid Therapeutics Inc OVID.O: Citigroup cuts target price to $3.5 from $4 |
* Pacs Group Inc PACS.N: Stephens initiates coverage with overweight rating and $31 PT |
* Pactiv Evergreen Inc PTVE.O: Citigroup cuts target price to $16 from $17 |
* Palantir Technologies Inc PLTR.N: Citigroup raises target price to $25 from $23 |
* Palantir Technologies Inc PLTR.N: D.A. Davidson raises target price to $24 from $19 |
* Palantir Technologies Inc PLTR.N: Deutsche Bank raises target price to $20 from $18 |
* Palantir Technologies Inc PLTR.N: HSBC raises target price to $23 from $22 |
* Palantir Technologies Inc PLTR.N: RBC raises target price to $9 from $5 |
* Paymentus Holdings Inc PAY.N: Citigroup raises target price to $22 from $20 |
* Perficient Inc PRFT.O: Alliance Global Partners cuts to neutral from buy |
* Perficient Inc PRFT.O: Barrington Research cuts to market perform from outperform |
* Petco Health and Wellness Co WOOF.O: Citigroup cuts target price to $1.75 from $2.85 |
* Pinnacle West Capital Corp PNW.N: Evercore ISI raises target price to $77 from $69 |
* Pliant Therapeutics Inc PLRX.O: Citigroup cuts target price to $44 from $45 |
* Pliant Therapeutics Inc PLRX.O: H.C. Wainwright cuts target price to $36 from $48 |
* Pliant Therapeutics Inc PLRX.O: Oppenheimer raises target price to $48 from $47 |
* Pliant Therapeutics Inc PLRX.O: RBC cuts target price to $45 from $54 |
* Post Holdings Inc POST.N: Barclays raises target price to $120 from $115 |
* Prime Medicine Inc PRME.O: Jefferies assumes coverage with buy rating; PT $15 vs $23 |
* Public Service Enterprise Group Inc PEG.N: RBC raises target price to $80 from $72 |
* Pyxis Oncology Inc PYXS.O: Jefferies assumes coverage with buy rating; PT $10 |
* Rani Therapeutics Holdings Inc RANI.O: H.C. Wainwright raises target to $13 from $12 |
* Regeneron Pharmaceuticals Inc REGN.O: UBS raises target price to $1,124 from $1,099 |
* Reinsurance Group of America Inc RGA.N: KBW raises target price to $235 from $220 |
* Rocket Companies Inc RKT.N: Piper Sandler raises target price to $13 from $12 |
* Rocket Lab USA Inc RKLB.O: Citigroup cuts target price to $5.45 from $6 |
* Root Inc ROOT.O: KBW raises target price to $80 from $70 |
* Rxsight Inc RXST.O: BTIG raises target price to $72 from $61 |
* Rxsight Inc RXST.O: JP Morgan raises target price to $75 from $62 |
* Rxsight Inc RXST.O: Needham raises target price to $75 from $64 |
* Rxsight Inc RXST.O: Oppenheimer raises target price to $72 from $61 |
* Sarepta Therapeutics Inc SRPT.O: Guggenheim raises target price to $148 from $145 |
* Schneider National Inc SNDR.N: Stephens cuts target price to $24 from $30 |
* Selective Insurance Group Inc SIGI.O: BMO cuts target price to $100 from $105 |
* ServiceNow Inc NOW.N: Baird raises target price to $885 from $870 |
* Shake Shack Inc SHAK.N: Stifel raises target price to $110 from $95 |
* Shoals Technologies Group Inc SHLS.O: Guggenheim cuts target price to $12 from $14 |
* Silverbow Resources Inc SBOW.N: Truist Securities raises target price to $47 from $45 |
* Slb SLB.N: BofA Global Research removes stock from its US 1 list |
* Southern Co SO.N: RBC raises target price to $84 from $80 |
* Spirit Airlines SAVE.N: Deutsche Bank cuts target price to $3 from $4 |
* Spirit Airlines SAVE.N: Evercore ISI cuts target price to $3 from $3.50 |
* Spirit Airlines SAVE.N: TD Cowen cuts target price to $3 from $4 |
* Stoke Therapeutics Inc STOK.O: Canaccord Genuity cuts target price to $20 from $21 |
* Summit Therapeutics Inc SMMT.O: Citigroup initiates coverage With Buy rating; PT $7 |
* Symbotic Inc SYM.O: Craig-Hallum raises target price to $60 from $55 |
* Symbotic Inc SYM.O: Deutsche Bank raises target price to $58 from $57 |
* Synovus Financial Corp SNV.N: D.A. Davidson raises target price to $47 from $43 |
* Talos Energy Inc TALO.N: Stephens cuts target price to $24 from $26 |
* Target Corp TGT.N: Citigroup raises to buy from neutral |
* Teradata Corp TDC.N: Barclays cuts target price to $35 from $39 |
* Teradata Corp TDC.N: BofA Global Research cuts price objective to $39 from $48 |
* Teradata Corp TDC.N: BofA Global Research cuts to underperform from neutral |
* Teradata Corp TDC.N: Evercore ISI cuts target price to $46 from $58 |
* Teradata Corp TDC.N: Guggenheim cuts target price to $60 from $66 |
* Teradata Corp TDC.N: RBC cuts target price to $44 from $48 |
* Teradata Corp TDC.N: TD Cowen cuts target price to $40 from $46 |
* Territorial Bancorp Inc TBNK.O: Piper Sandler raises target price to $8.50 from $8 |
* Territorial Bancorp Inc TBNK.O: Piper Sandler raises to neutral from underweight |
* Texas Roadhouse Inc TXRH.O: Guggenheim raises target price to $185 from $155 |
* Thredup Inc TDUP.O: Telsey Advisory Group cuts target price to $3 from $4 |
* Thredup Inc TDUP.O: Wedbush cuts target price to $3 from $4 |
* Transact Technologies Inc TACT.O: Craig-Hallum cuts target price to $7.5 from $9 |
* Travere Therapeutics Inc TVTX.O: Canaccord Genuity raises target price to $18 from $15 |
* Treehouse Foods Inc THS.N: Stifel cuts target price to $36 from $38 |
* Treehouse Foods Inc THS.N: TD Cowen cuts target price to $37 from $38 |
* Tyson Foods Inc TSN.N: Bernstein raises target price to $72 from $71 |
* Tyson Foods Inc TSN.N: BMO raises target price to $58 from $55 |
* Tyson Foods Inc TSN.N: JP Morgan raises target price to $61 from $59 |
* Tyson Foods Inc TSN.N: Piper Sandler raises target price to $57 from $55 |
* Ul Solutions Inc ULS.N: BofA Global Research initiates coverage with buy rating |
* Ul Solutions Inc ULS.N: BofA Global Research initiates coverage with PT $42 |
* UL Solutions Inc ULS.N: Jefferies initiates coverage with buy rating; price target $42 |
* Ul Solutions Inc ULS.N: Raymond James initiates with outperform rating and $42 PT |
* Ul Solutions Inc ULS.N: Stifel initiates with buy rating and $40 price target |
* Ul Solutions Inc ULS.N: UBS initiates coverage with neutral rating and PT $38 |
* Ulta Beauty Inc ULTA.O: Oppenheimer cuts target price to $475 from $500 |
* Ultra Clean Holdings Inc UCTT.O: Needham raises target price to $56 from $50 |
* Ultra Clean Holdings Inc UCTT.O: TD Cowen raises target price to $55 from $47 |
* Universal Health Services Inc UHS.N: RBC raises target price to $189 from $183 |
* USANA Health Sciences Inc USNA.N: D.A. Davidson cuts target price to $46 from $48 |
* Vale SA VALE.N: UBS raises to buy from neutral; raises target price to $15 from $13 |
* Varonis Systems Inc VRNS.O: RBC raises target price to $58 from $56 |
* Ventas Inc VTR.N: RBC raises target price to $52 from $50 |
* Vertex Pharmaceuticals Inc VRTX.O: Bernstein raises target price to $458 from $450 |
* Vertex Pharmaceuticals Inc VRTX.O: Leerink Partners raises PT to $529 from $511 |
* Vertex Pharmaceuticals Inc VRTX.O: Piper Sandler raises target price to $456 from $450 |
* Vertex Pharmaceuticals Inc VRTX.O: RBC raises target price to $424 from $417 |
* Vimeo Inc VMEO.O: Piper Sandler raises target price to $4.50 from $4 |
* Vistra Corp VST.N: Guggenheim raises target price to $100 from $48 |
* Vistra Corp VST.N: RBC raises target price to $95 from $30 |
* Walmart Inc WMT.N: UBS raises target price to $69 from $63 |
* Welltower Inc WELL.N: RBC raises target price to $101 from $99 |
* Western Midstream Partners LP WES.N: Mizuho raises target price to $39 from $34 |
* Westrock Co WRK.N: Truist Securities raises target price to $51 from $42 |
* Willscot Mobile Mini Holdings Corp WSC.O: D.A. Davidson cuts target price to $54 from $56 |
* Wolfspeed Inc WOLF.N: Deutsche Bank cuts target price to $25 from $30 |
* Zeta Global Holdings Corp ZETA.N: Barclays raises target price to $18 from $15 |
* Zeta Global Holdings Corp ZETA.N: Canaccord Genuity raises PT to $17 from $13 |
* Zeta Global Holdings Corp ZETA.N: Craig-Hallum raises target price to $22 from $15 |
* Zeta Global Holdings Corp ZETA.N: D.A. Davidson raises target price to $19 from $15 |
* Zeta Global Holdings Corp ZETA.N: Needham raises target price to $18 from $13 |
* Zeta Global Holdings Corp ZETA.N: Oppenheimer raises target price to $18 from $14 |
(Compiled by Bengaluru Newsroom)
</body></html>면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.
온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.
이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.